Search
Collplant Biotechnologies Ltd
CLGNAdd to Watchlist
0.340USD
-0.009-2.63%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
4.36MMarket Cap
LossP/E TTM
More Details of Collplant Biotechnologies Ltd Company
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Collplant Biotechnologies Ltd Info
Ticker SymbolCLGN
Company nameCollplant Biotechnologies Ltd
IPO dateSep 01, 1993
CEORotem (Eran)
Number of employees57
Security typeOrdinary Share
Fiscal year-endSep 01
Address4 Oppenheimer Street
CityREHOVOT
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code7670104
Phone972732325600
Websitehttps://www.collplant.com
Ticker SymbolCLGN
IPO dateSep 01, 1993
CEORotem (Eran)
Company Executives of Collplant Biotechnologies Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Gili Hart
Dr. Gili Hart
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--
FAQs
Who are the top five shareholders of Collplant Biotechnologies Ltd?
The top five shareholders of Collplant Biotechnologies Ltd are: Mr. Yehiel Tal
How many institutions hold shares of Collplant Biotechnologies Ltd (CLGN)?
As of 2026Q1, 35 institutions hold shares of Collplant Biotechnologies Ltd, with a combined market value of approximately 1.89M, accounting for 13.14% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -218892.00.
What is the biggest source of revenue for Collplant Biotechnologies Ltd?
In 2026Q1, the Revenues from licensing agreement business generated the highest revenue for Collplant Biotechnologies Ltd, amounting to 2.00M and accounting for 84.35% of total revenue.